Global Gouty Arthritis market size is expected to reach $5.06 billion by 2030 at 6.4%, segmented as by acute gouty arthritis, monosodium urate crystals-induced acute gout, acute gout attack (intermittent flares)
Read More
Global Gout Therapeutics market size is expected to reach $5.6 billion by 2030 at 11.8%, growing prevalence of gout fuels expansion in the gout therapeutics market
Read More
Global Gonorrhea Therapeutics market size is expected to reach $2.52 billion by 2030 at 4.9%, rising sti rates fuel market growth
Read More
Global Gonadotropin-Releasing Hormone (GnRH) Agonist market size is expected to reach $4.73 billion by 2030 at 2.5%, segmented as by leuprorelin, injectable leuprorelin, implantable leuprorelin
Read More
Global GM1 Gangliosidosis market size is expected to reach $0.96 billion by 2030 at 10.8%, rising adoption of gene therapy fuels growth in rare disease treatments
Read More
Global Glycomics or Glycobiology market size is expected to reach $4.66 billion by 2030 at 17%, glycomics and glycobiology market driven by increased demand for chronic disease medications
Read More
Global Glycomic Therapeutics market size is expected to reach $424.67 billion by 2030 at 17.6%, rising diabetes prevalence fuels growth in the glycomic therapeutics market
Read More
Global Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs market size is expected to reach $32.87 by 2030 at 16.2%, rising prevalence of obesity fueling the growth of the market due to increasing demand
Read More
Global Glomerulonephritis market size is expected to reach $14.66 billion by 2030 at 4.7%, rising prevalence of kidney disorders driving the market growth
Read More
Global Gliosarcoma market size is expected to reach $1.6 billion by 2030 at 5%, rising incidence of brain tumors and the growing need for gliosarcoma treatment
Read More